Simon Messner

4.7k total citations · 1 hit paper
26 papers, 2.5k citations indexed

About

Simon Messner is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Simon Messner has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Simon Messner's work include PARP inhibition in cancer therapy (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver physiology and pathology (5 papers). Simon Messner is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver physiology and pathology (5 papers). Simon Messner collaborates with scholars based in Switzerland, United States and Germany. Simon Messner's co-authors include Michael O. Hottiger, Jens M. Kelm, Matthias Altmeyer, Wolfgang Moritz, Claudia Escher, Paul O. Hassa, Irina Agarkova, Roland Bruderer, Yulia Butscheid and Saša M. Miladinović and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Simon Messner

25 papers receiving 2.5k citations

Hit Papers

Extending the Limits of Quantitative Proteome Profiling w... 2015 2026 2018 2022 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues
    2015 755 citations Roland Bruderer, Oliver M. Bernhardt et al. Molecular & Cellular Proteomics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Messner Switzerland 17 1.3k 764 446 389 386 26 2.5k
Doris Cassio France 35 1.5k 1.1× 745 1.0× 122 0.3× 122 0.3× 409 1.1× 77 3.0k
Barbara Sitek Germany 33 1.6k 1.2× 482 0.6× 96 0.2× 506 1.3× 300 0.8× 125 3.2k
Liang Zhao China 38 2.4k 1.8× 709 0.9× 183 0.4× 134 0.3× 58 0.2× 166 3.7k
Kun Guo China 33 1.7k 1.3× 803 1.1× 173 0.4× 90 0.2× 229 0.6× 122 3.3k
Pengyuan Yang China 35 3.4k 2.6× 816 1.1× 99 0.2× 137 0.4× 351 0.9× 113 5.4k
Alan J. Dickson United Kingdom 29 2.1k 1.6× 270 0.4× 162 0.4× 141 0.4× 73 0.2× 129 2.7k
Lingyun Dai China 24 1.3k 1.0× 215 0.3× 121 0.3× 205 0.5× 38 0.1× 72 2.0k
Guangfu Li United States 28 984 0.7× 821 1.1× 183 0.4× 28 0.1× 216 0.6× 96 2.4k

Countries citing papers authored by Simon Messner

Since Specialization
Citations

This map shows the geographic impact of Simon Messner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Messner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Messner more than expected).

Fields of papers citing papers by Simon Messner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Messner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Messner. The network helps show where Simon Messner may publish in the future.

Co-authorship network of co-authors of Simon Messner

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Messner. A scholar is included among the top collaborators of Simon Messner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Messner. Simon Messner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickinson, Stephanie, et al.. (2025). Incorporating Patient Input into the Target Product Profile. Therapeutic Innovation & Regulatory Science. 59(4). 659–667.
2.
Jiang, Jian, Simon Messner, Jens Kelm, et al.. (2019). Human 3D multicellular microtissues: An upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicology Letters. 312. 34–44. 17 indexed citations
3.
Guye, Patrick, et al.. (2018). A novel microtissue-based 3D human liver NASH model for drug discovery. Toxicology Letters. 295. S79–S79. 1 indexed citations
4.
Messner, Simon, Lisa Fredriksson, Volker M. Lauschke, et al.. (2017). Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues. PubMed. 4(1). 1–12. 55 indexed citations
5.
6.
Paech, Franziska, Simon Messner, Jochen Spickermann, et al.. (2017). Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072. Archives of Toxicology. 91(11). 3647–3662. 36 indexed citations
7.
Proctor, William R., Alison J. Foster, Jennifer Vogt, et al.. (2017). Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Archives of Toxicology. 91(8). 2849–2863. 219 indexed citations
8.
Hendriks, Delilah, et al.. (2016). Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Scientific Reports. 6(1). 35434–35434. 122 indexed citations
9.
Ghosh, Himanish, Simon Messner, Mario A. Acuña, et al.. (2016). Several posttranslational modifications act in concert to regulate gephyrin scaffolding and GABAergic transmission. Nature Communications. 7(1). 13365–13365. 55 indexed citations
10.
Hendriks, Delilah, et al.. (2016). 3D hepatic spheroid models for the detection and study of compounds with cholestatic liability. Toxicology Letters. 258. S134–S135. 1 indexed citations
11.
Kelm, Jens, et al.. (2015). Quantifying Efflux Activity in 3D Liver Spheroids. Genetic Engineering & Biotechnology News. 35(7). 14–15. 6 indexed citations
12.
Bruderer, Roland, Oliver M. Bernhardt, Tejas Gandhi, et al.. (2015). Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues. Molecular & Cellular Proteomics. 14(5). 1400–1410. 755 indexed citations breakdown →
13.
Kermanizadeh, Ali, Martin Roursgaard, Simon Messner, et al.. (2014). Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model. Particle and Fibre Toxicology. 11(1). 56–56. 70 indexed citations
14.
Fruhwürth, Stefanie, Werner J. Kovacs, Robert Bittman, et al.. (2014). Differential basolateral–apical distribution of scavenger receptor, class B, type I in cultured cells and the liver. Histochemistry and Cell Biology. 142(6). 645–655. 8 indexed citations
15.
Messner, Simon, Irina Agarkova, Wolfgang Moritz, & Jens M. Kelm. (2012). Multi-cell type human liver microtissues for hepatotoxicity testing. Archives of Toxicology. 87(1). 209–213. 247 indexed citations
16.
Rosenthal, Florian, Simon Messner, Bernd Roschitzki, et al.. (2011). Identification of Distinct Amino Acids as ADP-Ribose Acceptor Sites by Mass Spectrometry. Methods in molecular biology. 780. 57–66. 20 indexed citations
17.
Messner, Simon & Michael O. Hottiger. (2011). Histone ADP-ribosylation in DNA repair, replication and transcription. Trends in Cell Biology. 21(9). 534–542. 140 indexed citations
18.
Messner, Simon, Matthias Altmeyer, Hongtao Zhao, et al.. (2010). PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Research. 38(19). 6350–6362. 215 indexed citations
19.
Altmeyer, Matthias, Simon Messner, Paul O. Hassa, Monika Fey, & Michael O. Hottiger. (2009). Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Research. 37(11). 3723–3738. 283 indexed citations
20.
Elser, Michael, Lubor Borsig, Paul O. Hassa, et al.. (2008). Poly(ADP-Ribose) Polymerase 1 Promotes Tumor Cell Survival by Coactivating Hypoxia-Inducible Factor-1–Dependent Gene Expression. Molecular Cancer Research. 6(2). 282–290. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doris Cassio Breakdown of academic impact, for papers by Barbara Sitek Breakdown of academic impact, for papers by Liang Zhao Breakdown of academic impact, for papers by Kun Guo Breakdown of academic impact, for papers by Pengyuan Yang Breakdown of academic impact, for papers by Alan J. Dickson Breakdown of academic impact, for papers by Lingyun Dai Breakdown of academic impact, for papers by Guangfu Li
Rankless by CCL
2026